Learn / KYTX
NASDAQ: KYTX
Kyverna Therapeutics (KYTX) stock, explained like you're 5
Kyverna Therapeutics trades on the Nasdaq under the ticker KYTX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 395 million dollars.
- Ticker
- KYTX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 395 million dollars
Is Kyverna Therapeutics a small, medium or large cap company?
No. Kyverna Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 395 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Kyverna Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves KYTX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- KYTX Stock Soars After Hours: What’s Driving The Rally? (Stocktwits)
- Kyverna Therapeutics Sinks 13%: Here’s Why (Yahoo Finance)
- Kyverna Therapeutics Q3 2026 Earnings Date and Estimates (MarketBeat)
- A cell therapy showed sustained benefit after one dose for stiff person syndrome; Kyverna will present data. (Stock Titan)
- Why is Kyverna Therapeutics stock surging today? (Investing.com)
Follow KYTX in your daily brief
Each trading day at 5 PM ET we post what happened to Kyverna Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow KYTX
Questions about Kyverna Therapeutics stock
What does Kyverna Therapeutics do?
Kyverna Therapeutics trades on the Nasdaq under the ticker KYTX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 395 million dollars.
What is the ticker symbol for Kyverna Therapeutics?
Kyverna Therapeutics trades under the ticker KYTX on the Nasdaq.
What is Kyverna Therapeutics's market cap?
Kyverna Therapeutics is a small cap stock with a market cap of about 395 million dollars.
How does Kyverna Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves KYTX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow KYTX stock every day?
Add KYTX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.